Skip to content
Search for:
Home
About Us
Leadership
Board of Directors
Company History
Careers
Life Sciences
Applications
Cell-Based Assays
Gene Editing
Primary Cells
Protein Production
Stem Cells
TCR/CAR T
Resources
Application Notes
Posters
Primary Literature
Product Literature
Webinar
White Papers
Instruments
ATx
GTx
STx
VLX
Consumables
RUO PAs
PA Accessories
GMP PAs
PA Order/Quote Request
Distributors
Webinars Series
Vaccine
Products
Instruments
ATx
GTx
STx
VLX
Consumables
RUO PAs
PA Accessories
GMP PAs
PA Order / Quote Request
Resources
Applications
Cell-Based Assays
Gene Editing
Primary Cells
Protein Production
Stem Cells
TCR/CAR T
Publications
Application Notes
Posters
Primary Literature
Product Literature
Webinars
White Papers
Investors
News/Events
Press Releases
Upcoming Events
Virtual 3D booth
Media Contact
MaxCyte® Minutes
Contact Us
Search for:
Accelerating Vaccine Production Using a Nonviral Enabling Technology for Cell Engineering
Accelerating Vaccine Production Using a Nonviral Enabling Technology for Cell Engineering
St Jones
2020-12-02T17:35:20+00:00
When it comes to protein expression, manufacturers have a choice among a range of technologies for implementation.
Download PDF
Learn about cutting-edge applications, new resources, and upcoming events.
Subscribe to our e-Newsletter
Sign Up
Go to Top
